“In addition to protecting our proprietary nanoFIX Surface Technology, we are also defending our other areas of expertise, including implant construction, surgical methods, manufacturing processes and others,” said CEO Peter Ullrich.
Thus far, 18 patents have been issued or are currently pending for Titan Spine.
More Articles on Orthopedic Devices:
American Joint Replacement Registry Today & Tomorrow: Q&A With Director of Research Dr. Caryn Etkin
DiFusion CleanFUZE Clinical Trials Demonstrate Positive Outcomes
23 Spine Devices Receive FDA 510(k) Clearance in August
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.